IRF4 and acute lymphoblastic leukemia: This miRNA promotes the development of ALL by regulating the CBL-mediated IRF4/CDK6 axis (Cbl proto-oncogene protein and Interferon regulatory factor 4/cyclin-dependent kinase 6, respectively; by inhibiting CBL, ubiquitination of IRF4 and thus inhibition of CDK6) [25].